GBS(INBS) - 2026 Q2 - Quarterly Results

(Exact name of registrant as specified in its charter) FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of Earliest Event Reported): February 5, 2026 INTELLIGENT BIO SOLUTIONS INC. UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 (State of Incorporation) (Commission File Number) Delaware 001-39825 82-1512711 (IRS employer identification no.) 135 West, 41st Street, 5th Floor New York, NY 10036 (Address of principal exec ...